Buy the Dip: Novo Nordisk Setup Ahead of a Volume-Led Rebound
Novo Nordisk (NVO) has pulled back to the low-$30s on GLP-1 competition and headline volatility. The stock is trading at a modest P/E of 11.4, yields ~3.1%, and shows technical signs of near-term exhaustion. With average liquidity well above today's volumes and a recent pickup in short activity, a disciplined long at $38.90 targeting $52.00 (mid-te…